Jeremy Schmidt, APNP

NPI: 1184892622
Total Payments
$108,686
2024 Payments
$21,047
Companies
54
Transactions
893
Medicare Patients
1,488
Medicare Billing
$220,358

Payment Breakdown by Category

Other$76,274 (70.2%)
Food & Beverage$16,500 (15.2%)
Travel$14,719 (13.5%)
Consulting$1,095 (1.0%)
Gifts$59.40 (0.1%)
Education$38.44 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $76,274 82 70.2%
Food and Beverage $16,500 775 15.2%
Travel and Lodging $14,719 30 13.5%
Consulting Fee $1,095 2 1.0%
Gift $59.40 1 0.1%
Education $38.44 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $61,033 274 $0 (2024)
Lilly USA, LLC $31,112 173 $0 (2024)
MannKind Corporation $4,925 48 $0 (2023)
Abbott Laboratories $2,678 24 $0 (2024)
Zealand Pharma US, Inc. $2,338 19 $0 (2022)
AstraZeneca Pharmaceuticals LP $663.27 35 $0 (2022)
Dexcom, Inc. $655.82 11 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $565.37 29 $0 (2024)
Amgen Inc. $458.21 31 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $386.41 24 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $21,047 85 Lilly USA, LLC ($15,706)
2023 $33,566 255 Lilly USA, LLC ($14,535)
2022 $30,317 261 Novo Nordisk Inc ($26,275)
2021 $23,757 292 Novo Nordisk Inc ($19,689)

All Payment Transactions

893 individual payment records from CMS Open Payments — Page 1 of 36

Date Company Product Nature Form Amount Type
12/17/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $31.75 General
Category: Diabetes
12/17/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $30.81 General
Category: PAIN MANAGEMENT
12/10/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $21.77 General
Category: Cardio-renal
11/29/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $14.45 General
Category: Diabetes Care
11/18/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $13.35 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/18/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $11.51 General
Category: Diabetes
11/15/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage In-kind items and services $22.23 General
Category: Endocrinology
11/14/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $13.58 General
Category: Cardio-renal
11/12/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), SYNJARDY Food and Beverage In-kind items and services $22.35 General
Category: DIABETES
11/08/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $19.69 General
Category: Diabetes Care
11/08/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.73 General
Category: Diabetes
10/29/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), SYNJARDY Food and Beverage In-kind items and services $23.90 General
Category: DIABETES
10/24/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $5.60 General
Category: Diabetes
10/23/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.91 General
Category: Diabetes
10/04/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $6.88 General
Category: Diabetes
10/04/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $1.68 General
Category: Diabetes
09/26/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Diabetes
09/26/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $5.84 General
Category: Diabetes
09/24/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Diabetes
09/23/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $10.93 General
Category: Diabetes
09/19/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Diabetes
08/30/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $6.00 General
Category: Diabetes
08/29/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.41 General
Category: Diabetes
08/23/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $95.69 General
Category: Endocrinology
08/23/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $16.91 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 545 938 $250,394 $75,680
2022 7 537 936 $276,199 $88,362
2021 7 406 591 $157,639 $56,316
Total Patients
1,488
Total Services
2,465
Medicare Billing
$220,358
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 188 443 $154,018 $45,566 29.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 128 168 $42,322 $13,493 31.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 44 44 $18,656 $5,744 30.8%
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report Office 2023 101 192 $12,819 $4,062 31.7%
95250 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment Office 2023 30 30 $8,447 $3,059 36.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 25 25 $8,004 $2,295 28.7%
93923 Complete ultrasound study of arm and leg arteries Office 2023 12 19 $6,043 $1,406 23.3%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2023 17 17 $85.00 $54.57 64.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 203 531 $184,587 $58,423 31.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 106 106 $44,832 $14,328 32.0%
95250 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment Office 2022 61 66 $19,181 $7,137 37.2%
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report Office 2022 84 116 $7,859 $2,616 33.3%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2022 43 74 $8,246 $2,438 29.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 28 $6,791 $1,861 27.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 15 15 $4,704 $1,558 33.1%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 110 237 $78,547 $28,054 35.7%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 78 78 $31,468 $11,044 35.1%
95250 Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours Office 2021 48 49 $14,451 $5,856 40.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 41 53 $12,572 $4,536 36.1%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2021 41 80 $9,438 $3,185 33.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 21 21 $6,415 $1,908 29.7%
95251 Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours Office 2021 67 73 $4,748 $1,734 36.5%

About Jeremy Schmidt, APNP

Jeremy Schmidt, APNP is a Family healthcare provider based in New Braunfels, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1184892622.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeremy Schmidt, APNP has received a total of $108,686 in payments from pharmaceutical and medical device companies, with $21,047 received in 2024. These payments were reported across 893 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($76,274).

As a Medicare-enrolled provider, Schmidt has provided services to 1,488 Medicare beneficiaries, totaling 2,465 services with total Medicare billing of $220,358. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location New Braunfels, TX
  • Active Since 02/19/2008
  • Last Updated 10/16/2024
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1184892622

Products in Payments

  • Ozempic (Drug) $31,369
  • MOUNJARO (Drug) $20,652
  • Rybelsus (Drug) $18,305
  • RYBELSUS (Drug) $6,231
  • V-GO (Device) $4,332
  • FREESTYLE LIBRE 3 (Device) $2,534
  • ZEGALOGUE (Drug) $2,151
  • JARDIANCE (Drug) $718.29
  • FARXIGA (Drug) $663.27
  • Dexcom G6 Transmitter (Medical Supply) $593.93
  • AFREZZA (Drug) $593.28
  • Kerendia (Drug) $386.41
  • Korlym (Drug) $355.34
  • Vascepa (Drug) $282.14
  • TRULICITY (Drug) $260.20
  • Repatha (Biological) $246.32
  • HUMULIN (Drug) $225.67
  • BAQSIMI (Drug) $203.80
  • V-GO DISPOSABLE INSULIN DELIVERY (Device) $186.53
  • UNITHROID (Drug) $175.42

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in New Braunfels